Categories
Archives
Receive Email Updates
-
-
Certified Licensing Professionals, Inc., 2021 Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
- About Me
Warren D. Woessner Pages
Archives
Monthly Archives: April 2012
Prometheus Q/A – Which Side Are You On?
A guest post from Robin Chadwick of SLW. During the three weeks since the Supreme Court ruled that certain diagnostic claims are not eligible for patenting, four other patent cases have been impacted by this ruling. The Court is shaping … Continue reading
Posted in Patent Eligible Subject Matter
Tagged Patent Law, Prometheus, robin chadwick, Supreme Court, USPTO
1 Comment
Aventis v. Hospira – How to Meet the Therasense Standards
On April 9, 2012, The Fed. Cir. affirmed a holding by the district court that rendered two (then) Sanofi add-on patents on infusion vehicles for docetaxel unenforceable due to inequitable conduct. The inventors, particularly inventor/project manager Fabre, were found to have … Continue reading
Posted in Inequitable Conduct/Rule 56
Tagged Aventis v. Hospira, Fabre, Federal Circuit, Patent Law, Therasense, Warren Woessner
2 Comments
USPTO Encourages Prosecution After Final – Sort of
Although entry of any amendments after final rejection has always be discretionary with Examiners, for pretty much my entire career, I have had good luck continuing prosecution after final rejection – sometimes filing multiple Rule 116 amendments or making multiple … Continue reading
Posted in USPTO Practice and Policy
Tagged RCE, Rule 116 Amendment, USPTO, Warren Woessner
1 Comment